HLB Co., Ltd.

₩31,250As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:028300Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 15.13%
Div yield —
ROE (48.50%)
Biotechnology
Beta (5Y) 0.48
PE TTM —
TSR TTM (35.70%)
Mkt cap ₩4.154T
ROIC (7.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩30,326
(2.96%)
19.97%
Hold 0|10|6|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
325.84
332.82
344.43
366.05
13.79%
5.30%
3.67%
7.91%
Revenue₩B
283.8
286.0
282.7
293.3
3.16%
2.72%
(3.99%)
1.27%
Peers (US$3.063B)
Cap (US$)
PE
1.673B
—
Capital
TTM
5Y
10Y
Leveragex
0.499
(0.522)
(0.408)
EBIT/Intx
2.600
0.163
0.147
Own earn%
(8.54)
11.27
10.79
Sh yield%
7.16
34.35
31.58
Owners
Insiders/Inst%
14.29
31.82
Short interest%
1.63
SBC / revenue%
1.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
19–27
$1 testx
−0.1
Incr. ROIC%
6